Heron Therapeutics Inc vs Annaly Capital Management, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Annaly Capital Management, Inc. trades at $23.18 (market cap $17.44B). The key difference: Annaly Capital Management, Inc. is far larger — about 283.7× Heron Therapeutics Inc's market cap, and Annaly Capital Management, Inc. pays a 12.96% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | NLY | |
|---|---|---|
Market Cap | $61.47M | $17.44B |
Sector | Health | Financials |
52-Week High | $1.49 | $24.40 |
52-Week Low | $0.32 | $20.21 |
Enterprise Value | $168.21M | — |
Dividend Yield | — | 12.96% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →